SUBSCRIBE
SUBSCRIBE

Dimension Therapeutics

NEWS
Dimension Therapeutics was acquired by Ultragenyx in 2017.
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Deals
Bay Area’s Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics
September 18, 2017
 · 
3 min read
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma
Deals
Troubled Dimension Therapeutics Sold in All-Stock Deal
August 25, 2017
 · 
2 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Business
Dimension Therapeutics Pink Slips 25% of Workforce
June 27, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Cambridge’s Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data
February 1, 2017
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
BioCapital
3 Biotech Stocks Flying High Under-the-Radar
May 26, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Job Trends
Like Dimension Therapeutics, More Than Half of Yumanity’s Employees are Women
February 11, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Genetown
Cambridge’s Dimension Therapeutics Nabs $65 Million
April 21, 2015
 · 
2 min read
AWARDS
  • NextGen Class of 2015
IN THE PRESS
Genetown
Dimension Therapeutics Announces FDA Acceptance Of Investigational New Drug Application And Orphan Drug Designation For Lead Candidate DTX101 In Patients With Hemophilia B
September 10, 2015
 · 
3 min read
Business
Dimension Therapeutics Expands Its Board Of Directors With The Elections Of Industry Leaders Dr. Georges Gemayel And Arlene M. Morris
August 11, 2015
 · 
1 min read
Business
Dimension Therapeutics Further Expands Leadership Team; Appoints Accomplished Industry Leader Jean M. Franchi As Chief Financial Officer
August 6, 2015
 · 
1 min read
Business
Dimension Therapeutics Elects Industry Veteran And Finance Officer George Migausky To Its Board Of Directors
June 10, 2015
 · 
1 min read
Business
Dimension Therapeutics Announces Expansion Of Management Team As Company Advances Lead Programs Toward The Clinic
June 2, 2015
 · 
1 min read
Business
Dimension Therapeutics Hires a Team of Pharma Vets as Company Advances Lead Programs Toward Clinic
June 2, 2015
 · 
7 min read
Business
Dimension Therapeutics Announces Appointments Of Renowned Thought Leaders To Its Scientific Advisory Committee And Clinical Advisory Boards
May 21, 2015
 · 
1 min read
Genetown
Dimension Therapeutics To Participate In 3rd Annual Piper Jaffray Genomerx Symposium
May 13, 2015
 · 
1 min read
Genetown
Dimension Therapeutics To Develop Gene Therapy Treatments For Patients With Ornithine Transcarbamylase (OTC) Deficiency And Glycogen Storage Disease Type Ia (Gsdia)
April 23, 2015
 · 
5 min read
Business
RegenRx And Dimension Therapeutics Add Development Of Treatments For Two Metabolic Diseases To Exclusive License Agreement
April 23, 2015
 · 
2 min read
Load More